Plain-English translation of NCT06877637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The BILLIONSTARS study is following 150 patients with hepatocellular carcinoma (liver cancer) or cholangiocarcinoma (bile duct cancer) who are receiving standard cancer treatment. Researchers will collect blood samples and ask about your quality of life at different time points to understand how your tumor responds to treatment and what happens over time.
Doctors need better ways to monitor how these cancers respond to treatment and predict which patients will do well. By studying blood markers and tracking patients closely during treatment, researchers hope to improve how they care for people with these diseases.
You likely qualify if…
You likely don't qualify if…
You will receive your standard cancer treatment as planned by your medical team—the study does not change your treatment. A research nurse will take blood samples when you come in for your regular treatment visits. You will fill out quality-of-life questionnaires at the start of the study and again after 3 and 6 months. You may also be asked to consent to having tumor tissue samples stored for future research.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Sweden